Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs N-Acetyl Cysteine for Uterine Leiomyoma Volume
NCT06115408Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest, acetylcysteine in uterine leiomyoma, sponsored by Ain Shams University. Started Sep 2023; status: completed.
02
Drugs
dienogestacetylcysteine
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT06115408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06115408.